Skip to content

Baltimore News Journal – Lifestyle

Author: ODDIFACT

ODDIFACT Receives European Commission Orphan Drug Designation for Infliximab in Kawasaki Disease

May 21, 2026

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.